![]() Serious - Use Alternative (1)sodium acid phosphate and potassium phosphates, IV both increase serum potassium. Separate dosing of tetracyclines from these products. Multivalent cation-containing products may impair absorption of tetracyclines, which may decrease its efficacy. Applies only to oral form of both agents. Monitor Closely (1)sodium acid phosphate will decrease the level or effect of omadacycline by inhibition of GI absorption. Monitor Closely (1)sodium acid phosphate decreases levels of methylenedioxymethamphetamine by increasing renal clearance. Monitor Closely (1)sodium acid phosphate decreases levels of methamphetamine by increasing renal clearance. Monitor Closely (1)sodium acid phosphate decreases levels of lisdexamfetamine by increasing renal clearance. Monitor Closely (1)sodium acid phosphate decreases levels of dextroamphetamine by increasing renal clearance. Monitor Closely (1)sodium acid phosphate and deflazacort both decrease serum potassium. Studies in monkeys showed concurrent use with calcium, aluminum, or iron caused significantly decreased plasma levels. Baloxavir may bind to polyvalent cations resulting in decreased absorption. Serious - Use Alternative (1)sodium acid phosphate will decrease the level or effect of baloxavir marboxil by cation binding in GI tract. Sodium acid phosphate will decrease the level or effect of sarecycline by inhibition of GI absorption. Sodium acid phosphate will decrease the level or effect of omadacycline by inhibition of GI absorption. Sodium acid phosphate decreases levels of methylenedioxymethamphetamine by increasing renal clearance. Sodium acid phosphate decreases levels of methamphetamine by increasing renal clearance. Sodium acid phosphate decreases levels of lisdexamfetamine by increasing renal clearance. Sodium acid phosphate decreases levels of dextroamphetamine by increasing renal clearance. Sodium acid phosphate and deflazacort both decrease serum potassium. Sodium acid phosphate and potassium phosphates, IV both increase serum potassium. Sodium acid phosphate will decrease the level or effect of baloxavir marboxil by cation binding in GI tract. Coadministration of various sodium phosphate preparations are known to cause electrolyte disturbances and hypovolemia. Sodium phosphate rectal, sodium acid phosphate.Įither increases effects of the other by pharmacodynamic synergism. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |